Chemical Component Summary

NameCisplatin
Identifiersbis(chloranyl)-bis($l^{4}-azanyl)platinum
FormulaCl2 H6 N2 Pt
Molecular Weight300.05
TypeNON-POLYMER
Isomeric SMILESN|[Pt](|N)(Cl)Cl
InChIInChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2
InChIKeyLXZZYRPGZAFOLE-UHFFFAOYSA-L

Chemical Details

Formal Charge0
Atom Count11
Chiral Atom Count0
Bond Count10
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00515 
NameCisplatin
Groupsapproved
DescriptionCisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
Synonyms
  • Cisplatin
  • cisplatino
  • cis-diamminedichloroplatinum(II)
  • Cis-DDP
  • CDDP
Brand Names
  • Cisplatin
  • Platinol-AQ
  • PMS-cisplatin
  • Cisplatin Inj 1mg/ml
  • Cisplatin Injection
IndicationFor the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
Categories
  • Antineoplastic Agents
  • Antineoplastic and Immunomodulating Agents
  • BCRP/ABCG2 Substrates
  • Cardiotoxic antineoplastic agents
  • Chlorine Compounds
ATC-CodeL01XA01
CAS number15663-27-1

Drug Targets

NameTarget SequencePharmacological ActionActions
DNA-unknowncross-linking/alkylation
DNA-3-methyladenine glycosylaseMVTPALQMKKPKQFCRRMGQKKQRPARAGQPHSSSDAAQAPAEQPHSSSD...unknown
Alpha-2-macroglobulinMGKNKLLHPSLVLLLLVLLPTDASVSGKPQYMVLVPSLLHTETTEKGCVL...unknown
SerotransferrinMRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIP...unknown
Copper transport protein ATOX1MPKHEFSVDMTCGGCAEAVSRVLNKLGGVKYDIDLPNKKVCIESEHSMDT...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682